{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:16:28Z","timestamp":1761178588546,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.canrad.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T05:18:03Z","timestamp":1662355083000},"page":"865-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quel apport de la modulation d\u2019intensit\u00e9 pour la radioth\u00e9rapie des cancers du rectum\u00a0?"],"prefix":"10.1016","volume":"26","author":[{"given":"Y.","family":"Pointreau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.06.001_bib0155","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3\u00a0trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0160","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3\u00a0trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canrad.2021.11.002","article-title":"Rectal cancer radiotherapy","volume":"26","author":"Vendrely","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.001_bib0170","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.canrad.2016.07.043","article-title":"Radioth\u00e9rapie des cancers du rectum","volume":"20","author":"Peiffert","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.001_bib0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.canrad.2010.03.013","article-title":"Normal tissue tolerance to external beam radiation therapy: small bowel","volume":"14","author":"Martin","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.06.001_bib0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2007.06.066","article-title":"The dose-volume relationship of small bowel irradiation and acute grade 3\u00a0diarrhea during chemoradiotherapy for rectal cancer","volume":"70","author":"Robertson","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.001_bib0185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ijrobp.2012.09.036","article-title":"Small bowel dose parameters predicting grade \u2265 3\u00a0acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques","volume":"85","author":"Banerjee","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.001_bib0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1748-717X-6-63","article-title":"Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma","volume":"6","author":"Mok","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1748-717X-8-181","article-title":"A comparison of dosimetric parameters between tomotherapy and three-dimensional conformal radiotherapy in rectal cancer","volume":"8","author":"Yu","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1748-717X-5-14","article-title":"Neoadjuvant chemoradiation of rectal cancer with volumetric modulated arc therapy: summary of technical and dosimetric features and early clinical experience","volume":"5","author":"Richetti","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0205","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1748-717X-5-17","article-title":"Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications","volume":"5","author":"Arbea","year":"2010","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0210","first-page":"4935","article-title":"Dosimetric comparison between intensity modulated radiotherapy and 3\u00a0dimensional conformal radiotherapy in the treatment of rectal cancer","volume":"17","author":"Simson","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.canrad.2022.06.001_bib0215","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.radonc.2016.09.010","article-title":"Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer","volume":"121","author":"Ng","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijrobp.2015.05.005","article-title":"NRG Oncology Radiation Therapy Oncology Group 0822: a phase 2\u00a0study of preoperative chemoradiation therapy using intensity modulated radiation therapy in combination with capecitabine and oxaliplatin for patients with locally advanced rectal cancer","volume":"93","author":"Hong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.001_bib0225","first-page":"137","article-title":"Acute gastrointestinal toxicity and tumor response with preoperative intensity modulated radiation therapy for rectal cancer","volume":"6","author":"Parekh","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.canrad.2022.06.001_bib0230","first-page":"891067","article-title":"Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits","volume":"2012","author":"Jabbour","year":"2012","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0235","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.ijrobp.2011.01.051","article-title":"Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer","volume":"82","author":"Samuelian","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.001_bib0240","doi-asserted-by":"crossref","first-page":"646211","DOI":"10.3389\/fonc.2021.646211","article-title":"Effect of Pelvic Bone Marrow Sparing Intensity Modulated Radiation Therapy on Acute Hematologic Toxicity in Rectal Cancer Patients Undergoing Chemo-Radiotherapy","volume":"11","author":"Huang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13014-018-1187-7","article-title":"Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer","volume":"13","author":"Dapper","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0250","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1259\/bjr\/86650067","article-title":"Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II\/III trials","volume":"78","author":"Hartley","year":"2005","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2013.10.026","article-title":"Preoperative intensity-modulated and image-guided radiotherapy with a simultaneous integrated boost in locally advanced rectal cancer: report on late toxicity and outcome","volume":"110","author":"Engels","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijrobp.2011.04.060","article-title":"Quantification of organ motion during chemoradiotherapy of rectal cancer using cone-beam computed tomography","volume":"81","author":"Chong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.001_bib0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13014-014-0311-6","article-title":"Analysis of motion of the rectum during preoperative intensity modulated radiation therapy for rectal cancer using cone-beam computed tomography","volume":"10","author":"Yamashita","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0270","doi-asserted-by":"crossref","first-page":"619852","DOI":"10.3389\/fonc.2021.619852","article-title":"MR-Guided Radiotherapy for Rectal Cancer: Current Perspective on Organ Preservation","volume":"11","author":"Boldrini","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.06.001_bib0275","first-page":"129","article-title":"Predictors of acute gastrointestinal toxicity during pelvic chemoradiotherapy in patients with rectal cancer","volume":"6","author":"Yang","year":"2013","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.canrad.2022.06.001_bib0280","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1186\/s12885-015-1812-x","article-title":"Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy","volume":"15","author":"Dr\u00f6ge","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2022.06.001_bib0285","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2016.08.031","article-title":"Acute toxicity and tumor response in locally advanced rectal cancer after preoperative chemoradiation therapy with shortening of the overall treatment time using intensity-modulated radiation therapy with simultaneous integrated boost: a phase 2\u00a0trial","volume":"96","author":"But-Hadzic","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.06.001_bib0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jrr\/rrw098","article-title":"A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma","volume":"58","author":"Huang","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.canrad.2022.06.001_bib0295","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.7150\/jca.21237","article-title":"A phase II trial of preoperative concurrent chemotherapy and dose escalated intensity modulated radiotherapy (IMRT) for locally advanced rectal cancer","volume":"8","author":"Tey","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.canrad.2022.06.001_bib0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fonc.2017.00225","article-title":"Comparative Analysis of Efficacy, Toxicity, and Patient-Reported Outcomes in Rectal Cancer Patients Undergoing Preoperative 3D Conformal Radiotherapy or VMAT","volume":"7","author":"Regnier","year":"2017","journal-title":"Front Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:36:30Z","timestamp":1761136590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":30,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1278321822001044"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.001","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quel apport de la modulation d\u2019intensit\u00e9 pour la radioth\u00e9rapie des cancers du rectum\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}